Biomedcode Hellas SA - nicht nehmen, doppelt We are a niche Contract Research Organization (CRO) providing full pre-clinical drug evaluation services for inflammatory, autoimmune and related diseases. We generate, own and operate unique humanized transgenic mouse models mimicking Rheumatoid Arthritis, Intestinal Inflammation, Multiple Sclerosis and other diseases. In addition to our proprietary humanized mouse models we also offer a number of standard induced models of disease such as CIA, CAIA, EAE, induced colitis, and others. Moreover, our company employs state of the art technological platforms for comprehensive phenotyping of disease progression and response to therapy. To sustain its lead in preclinical drug evaluation outsourcing services, BioMedCode maintains a highly active R&D program that aims to generate and exploit novel humanized animal disease models. In the context of its R&D activities, we are a partner in several European FP6 and FP7 consortia, such as the Masterswitch and Inflacare Integrated projects and the MUGEN Network of Excellence, and plans to expand these collaborations while intensifying its R&D efforts.